Growth Metrics

Valion Bio (TIVC) Change in Cash (2021 - 2025)

Valion Bio has reported Change in Cash over the past 5 years, most recently at $9.2 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 5017.11% year-over-year to $9.2 million; the TTM value through Dec 2025 reached $10.6 million, up 864.03%, while the annual FY2025 figure was $10.6 million, 864.03% up from the prior year.
  • Change in Cash for Q4 2025 was $9.2 million at Valion Bio, up from $2.3 million in the prior quarter.
  • Over five years, Change in Cash peaked at $12.1 million in Q4 2021 and troughed at -$2.8 million in Q4 2022.
  • A 5-year average of $580050.0 and a median of -$609500.0 in 2021 define the central range for Change in Cash.
  • Biggest five-year swings in Change in Cash: crashed 389.64% in 2022 and later skyrocketed 5017.11% in 2025.
  • Year by year, Change in Cash stood at $12.1 million in 2021, then tumbled by 123.18% to -$2.8 million in 2022, then surged by 36.89% to -$1.8 million in 2023, then soared by 89.46% to -$187000.0 in 2024, then skyrocketed by 5017.11% to $9.2 million in 2025.
  • Business Quant data shows Change in Cash for TIVC at $9.2 million in Q4 2025, $2.3 million in Q3 2025, and $515000.0 in Q2 2025.